Sindrome di Rasmussen (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Sindrome di Rasmussen" in Italian language version.

refsWebsite

Global rank Italian rank

9doi.org

2^nd place

7^th place

8nih.gov

4^th place

9^th place

3archive.org

6^th place

8^th place

3oadoi.org

799^th place

22^nd place

1oxfordjournals.org

1,389^th place

732^nd place

archive.org

Rasmussen T, Olszewski J, Lloyd-Smith D, Focal seizures due to chronic localized encephalitis, in Neurology, vol. 8, n. 6, 1958, pp. 435-45, DOI:10.1212/WNL.8.6.435, PMID 13566382.
Watson R, Jiang Y, Bermudez I, L Houlihan, L Clover, K McKnight, JH Cross, IK Hart e A Roubertie, Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis, in Neurology, vol. 63, n. 1, 2004, pp. 43-50, DOI:10.1212/01.WNL.0000132651.66689.0F, PMID 15249609.
YM Hart, Cortez, Andermann e Hwang, Fish, Medical treatment of Rasmussen syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients, in Neurology, vol. 44, n. 6, 1994, pp. 1030-1036, DOI:10.1212/WNL.44.6.1030, PMID 8208394, 8208394.

doi.org

dx.doi.org

Rasmussen T, Olszewski J, Lloyd-Smith D, Focal seizures due to chronic localized encephalitis, in Neurology, vol. 8, n. 6, 1958, pp. 435-45, DOI:10.1212/WNL.8.6.435, PMID 13566382.
Michael P. Rassner, van Velthoven-Wurster, Vera; Ramantani, Georgia; Feuerstein, Thomas J., Altered transporter-mediated neocortical GABA release in Rasmussen encephalitis, in Epilepsia, vol. 54, n. 3, marzo 2013, pp. e41–e44, DOI:10.1111/epi.12093.
Bien CG, Granata T, Antozzi C, Cross JH, Dulac O, Kurthen M, Lassmann H, Mantegazza R, Villemure JG, Spreafico R, Elger CE, Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement, in Brain, vol. 128, Pt 3, 2005, pp. 454-71, DOI:10.1093/brain/awh415, PMID 15689357.
Rogers SW, Andrews PI, Gahring LC, T Whisenand, K Cauley, B Crain, T. Hughes, S. Heinemann e J. McNamara, Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis, in Science, vol. 265, n. 5172, 1994, pp. 648-51, DOI:10.1126/science.8036512, PMID 8036512.
Watson R, Jiang Y, Bermudez I, L Houlihan, L Clover, K McKnight, JH Cross, IK Hart e A Roubertie, Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis, in Neurology, vol. 63, n. 1, 2004, pp. 43-50, DOI:10.1212/01.WNL.0000132651.66689.0F, PMID 15249609.
Takahashi Y, Mori H, Mishina M, Masahiko Watanabe, Naomi Kondo, Jiro Shimomura, Yuko Kubota, Kazumi Matsuda e Katsuyuki Fukushima, Autoantibodies and cell-mediated autoimmunity to NMDA-type GluRepsilon2 in patients with Rasmussen's encephalitis (RE) and chronic progressive epilepsia partialis continua, in Epilepsia, vol. 46, Suppl 5, 2005, pp. 152-158, DOI:10.1111/j.1528-1167.2005.01024.x, PMID 15987271.
Varadkar S, Bien CG, Kruse CA, Jensen FE, Bauer J, Pardo CA, Vincent A, Mathern GW, Cross JH, Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances, in Lancet Neurol, vol. 13, n. 2, 2014, pp. 195-205, DOI:10.1016/S1474-4422(13)70260-6, PMC 4005780, PMID 24457189.
Owens GC, Chang JW, Huynh MN, Chirwa T, Vinters HV, Mathern GW, Evidence for Resident Memory T Cells in Rasmussen Encephalitis, in Front Immunol, vol. 7, 2016, p. 64, DOI:10.3389/fimmu.2016.00064, PMC 4763066, PMID 26941743.
YM Hart, Cortez, Andermann e Hwang, Fish, Medical treatment of Rasmussen syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients, in Neurology, vol. 44, n. 6, 1994, pp. 1030-1036, DOI:10.1212/WNL.44.6.1030, PMID 8208394, 8208394.

nih.gov

ncbi.nlm.nih.gov

Rasmussen T, Olszewski J, Lloyd-Smith D, Focal seizures due to chronic localized encephalitis, in Neurology, vol. 8, n. 6, 1958, pp. 435-45, DOI:10.1212/WNL.8.6.435, PMID 13566382.
Bien CG, Granata T, Antozzi C, Cross JH, Dulac O, Kurthen M, Lassmann H, Mantegazza R, Villemure JG, Spreafico R, Elger CE, Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement, in Brain, vol. 128, Pt 3, 2005, pp. 454-71, DOI:10.1093/brain/awh415, PMID 15689357.
Rogers SW, Andrews PI, Gahring LC, T Whisenand, K Cauley, B Crain, T. Hughes, S. Heinemann e J. McNamara, Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis, in Science, vol. 265, n. 5172, 1994, pp. 648-51, DOI:10.1126/science.8036512, PMID 8036512.
Watson R, Jiang Y, Bermudez I, L Houlihan, L Clover, K McKnight, JH Cross, IK Hart e A Roubertie, Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis, in Neurology, vol. 63, n. 1, 2004, pp. 43-50, DOI:10.1212/01.WNL.0000132651.66689.0F, PMID 15249609.
Takahashi Y, Mori H, Mishina M, Masahiko Watanabe, Naomi Kondo, Jiro Shimomura, Yuko Kubota, Kazumi Matsuda e Katsuyuki Fukushima, Autoantibodies and cell-mediated autoimmunity to NMDA-type GluRepsilon2 in patients with Rasmussen's encephalitis (RE) and chronic progressive epilepsia partialis continua, in Epilepsia, vol. 46, Suppl 5, 2005, pp. 152-158, DOI:10.1111/j.1528-1167.2005.01024.x, PMID 15987271.
Varadkar S, Bien CG, Kruse CA, Jensen FE, Bauer J, Pardo CA, Vincent A, Mathern GW, Cross JH, Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances, in Lancet Neurol, vol. 13, n. 2, 2014, pp. 195-205, DOI:10.1016/S1474-4422(13)70260-6, PMC 4005780, PMID 24457189.
Owens GC, Chang JW, Huynh MN, Chirwa T, Vinters HV, Mathern GW, Evidence for Resident Memory T Cells in Rasmussen Encephalitis, in Front Immunol, vol. 7, 2016, p. 64, DOI:10.3389/fimmu.2016.00064, PMC 4763066, PMID 26941743.
YM Hart, Cortez, Andermann e Hwang, Fish, Medical treatment of Rasmussen syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients, in Neurology, vol. 44, n. 6, 1994, pp. 1030-1036, DOI:10.1212/WNL.44.6.1030, PMID 8208394, 8208394.

oadoi.org

Michael P. Rassner, van Velthoven-Wurster, Vera; Ramantani, Georgia; Feuerstein, Thomas J., Altered transporter-mediated neocortical GABA release in Rasmussen encephalitis, in Epilepsia, vol. 54, n. 3, marzo 2013, pp. e41–e44, DOI:10.1111/epi.12093.
Rogers SW, Andrews PI, Gahring LC, T Whisenand, K Cauley, B Crain, T. Hughes, S. Heinemann e J. McNamara, Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis, in Science, vol. 265, n. 5172, 1994, pp. 648-51, DOI:10.1126/science.8036512, PMID 8036512.
Takahashi Y, Mori H, Mishina M, Masahiko Watanabe, Naomi Kondo, Jiro Shimomura, Yuko Kubota, Kazumi Matsuda e Katsuyuki Fukushima, Autoantibodies and cell-mediated autoimmunity to NMDA-type GluRepsilon2 in patients with Rasmussen's encephalitis (RE) and chronic progressive epilepsia partialis continua, in Epilepsia, vol. 46, Suppl 5, 2005, pp. 152-158, DOI:10.1111/j.1528-1167.2005.01024.x, PMID 15987271.

oxfordjournals.org

brain.oxfordjournals.org

Bien CG, Granata T, Antozzi C, Cross JH, Dulac O, Kurthen M, Lassmann H, Mantegazza R, Villemure JG, Spreafico R, Elger CE, Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement, in Brain, vol. 128, Pt 3, 2005, pp. 454-71, DOI:10.1093/brain/awh415, PMID 15689357.